Ind-Swift Laboratories Ltd. — Share Issue/Capital Change 2025

Aug 1, 2025

==> picture [476 x 85] intentionally omitted <==

Date: 1[st] August, 2025

Ref: ISLL:CH:2025	Date: 1st August, 2
To	To
Department of Corporate Services,	Department of Corporate Services,
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers,	Exchange Plaza, 5th Floor
25th Floor, Dalal Street,	Plot No. C/2, G-Block,
Mumbai 400 001	Bandra Kurla Complex, Bandra (E),
	Mumbai 400 051
BSE Scrip Code: 532305	NSE Symbol: INDSWFTLAB

Subject: Outcome of the meeting of the Preferential Issue Committee of the Board of Directors of Ind-Swift Laboratories Limited (“the Company”) in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/Ma’am,

With reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good office that the Preferential Issue Committee of the Board of Directors of Ind-Swift Laboratories Limited (“the Company”) at their meeting held on Friday, August 01, 2025, has, inter alia, considered and approved the allotment of 11,00,000 Equity Shares of face value of ₹ 10/- each pursuant to the conversion of 11,00,000 Fully Convertible Warrants (“Warrants”) , allotted on August 30, 2024, at an issue price of ₹ 121/- each to Essix Biosciences Limited, belonging to Promoter & Promoter Group on preferential basis.

Consequent to the said allotment, the Paid-up Equity Share Capital of the Company stands increased to ₹73,48,68,600/- (Rupees Seventy-Three Crore Forty-Eight Lakh Sixty-Eight Thousand and Six Hundred Only) divided into 7,34,86,860 (Seven Crore Thirty-Four Lakh Eighty-Six Thousand Eight Hundred and Sixty) Equity Shares of face value of ₹10/- each.

Details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, with respect to the Preferential Allotment is enclosed as Annexure A .

The meeting of the Preferential Issue Committee of the Board of Directors was commenced at 11:45 A.M. and concluded at 12:30 P.M.

This is for your information and records.

Thanking you, Yours faithfully, For Ind-Swift Laboratories Limited Pardeep Digitally signed by Pardeep Verma Verma Date: 2025.08.01 12:36:59 +05'30' Pardeep Verma VP-Corporate Affairs & Company Secretary

Annexure A

==> picture [476 x 85] intentionally omitted <==

Details on Preferential Allotment in terms of SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024:

==> picture [421 x 341] intentionally omitted <==

----- Start of picture text -----

S. No. Particulars Disclosures
1. Type of securities proposed to be Equity shares with face value of ₹10/- each
issued pursuant to the conversion of warrants.
2. Type of issuance Preferential allotment under Chapter V of the
SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018 and other
applicable law.
3. Total number of securities proposed Allotment of 11,00,000 equity shares of face
to be issued or total amount for which value ₹10/- each, pursuant to conversion of
the securities will be issued 11,00,000 Fully Convertible Warrants
(“Warrants”) , against the receipt of the
balance subscription amount aggregating to ₹
9,98,25,000/-
4. Name and number of the Investor(s) Essix Biosciences Limited
5. Post allotment of securities- outcome Pursuant to the aforesaid allotment, the issued,
of the subscription subscribed and paid-up share capital of the
Company stands increased in the manner as set
out in the letter above.
6. Issue price / allotted price (in case of Rs. 121/- (Rupees One Hundred Twenty-One
convertibles) Only) per Equity Share.
7. In case of convertibles - The allottee mentioned above have exercised
intimation on conversion of securities their rights and converted their 11,00,000
or on lapse of the tenure of the Warrants into Equity Shares.
instrument
----- End of picture text -----

Pardeep Digitally signed by Pardeep Verma Verma Date: 2025.08.01 12:37:34 +05'30'